AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28692407 — intervention group
Group type: EXPERIMENTAL
Intervention: History of drug overdose
Number of subjects: 440
Study 28692407 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 440
Study 28692407 — intervention group
Group type: EXPERIMENTAL
Intervention: Homelessness
Number of subjects: 440
Study 28692954 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality-targeted interventions
Number of subjects: 154
Study 28693058 — intervention group
Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 0
Study 28693366 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarucizumab (5 g intravenous)
Number of subjects: 503
Study 28693491 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital tracheal intubation (TI) by physician-staffed HEMS
Number of subjects: 1265
Study 28693521 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program
Number of subjects: 181
Study 28693521 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary physiotherapy (PPT)
Number of subjects: 181
Study 28693521 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 181
Study 28693521 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pulmonary rehabilitation)
Number of subjects: 181
Study 28693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Disorganized symptoms
Number of subjects: 1391
Study 28693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness insight
Number of subjects: 1391
Study 28693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognition
Number of subjects: 1391
Study 28693755 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative symptoms
Number of subjects: 1391
Study 28693934 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential Frailty Toolset (EFT)
Number of subjects: 1020
Study 28694253 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion Intervention led by an interdisciplinary care leader (ICL) for 6 months
Number of subjects: 30
Study 28694253 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary care leader (ICL) hours
Number of subjects: 30
Study 28694340 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 0
Study 28694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers non-withdrawal during acute heart failure
Number of subjects: 5005
Study 28694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers non-withdrawal during acute heart failure (ADCHF only)
Number of subjects: 5005
Study 28694343 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers non-withdrawal
Number of subjects: 5005
Study 28694343 — intervention group
Group type: COMPARATOR
Intervention: Beta blockers withdrawal
Number of subjects: 5005
Study 28694834 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 76
Study 28694840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat (LF) diet
Number of subjects: 21
Study 28694840 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index (LGI) diet
Number of subjects: 21
Study 28694840 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low carbohydrate (VLC) diet
Number of subjects: 21
Study 28694840 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (general)
Number of subjects: 21
Study 28694991 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week, home-based, online-streamed yoga intervention
Number of subjects: 0
Study 28694991 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28696231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafithromycin 800 mg once daily for 3 days
Number of subjects: 37
Study 28697406 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin or ibuprofen (or both)
Number of subjects: 3587
Study 28697406 — intervention group
Group type: COMPARATOR
Intervention: Control group (z-score <-2)
Number of subjects: 3587
Study 28697693 — intervention group
Group type: EXPERIMENTAL
Intervention: VBX Stent Graft
Number of subjects: 134
Study 28697762 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfer intervention
Number of subjects: 1214
Study 28698106 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss in knee extensor strength in women concurrent with symptomatic progression
Number of subjects: 1785
Study 28698106 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss in knee flexor strength in women concurrent with symptomatic progression
Number of subjects: 1785
Study 28698106 — intervention group
Group type: COMPARATOR
Intervention: Loss in knee extensor strength in women without symptomatic progression
Number of subjects: 1785
Study 28698106 — intervention group
Group type: COMPARATOR
Intervention: Loss in knee flexor strength in women without symptomatic progression
Number of subjects: 1785
Study 28698106 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss in knee extensor and flexor strength concurrent with radiographic progression
Number of subjects: 1785
Study 28698106 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior change in muscle strength with symptomatic or radiographic progression
Number of subjects: 1785
Study 28698323 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-TnT assay at T0
Number of subjects: 48
Study 28698323 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-TnT assay at T2
Number of subjects: 48
Study 28698323 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-TnT assay at T6
Number of subjects: 48
Study 28698330 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological therapy (specific biologic agent not mentioned)
Number of subjects: 60
Study 28698343 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium assessment at 30 min and 60 min following tracheal tube removal using the 3-min Diagnostic Confusion Assessment Method and the Richmond Agitation and Sedation Scale.
Number of subjects: 100
Study 28698343 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium assessment over postoperative days 1-5 using the Confusion Assessment Method (CAM), CAM for the Intensive Care Unit, and structured chart review.
Number of subjects: 100
Study 28698343 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis to test the predictive value of immediately postoperative delirium.
Number of subjects: 100
Study 28698344 — intervention group
Group type: EXPERIMENTAL
Intervention: PA/MD model (physician assistants and medical doctors)
Number of subjects: 2292
Study 28698344 — intervention group
Group type: COMPARATOR
Intervention: MD model (only medical doctors)
Number of subjects: 2292
Study 28698603 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially methylated BRCA1 and CRISP2 regions
Number of subjects: 16
Study 28698603 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially methylated regions (DMR) related to impaired oxidative stress, DNA repair, and inflammatory pathways
Number of subjects: 16
Study 28699212 — intervention group
Group type: EXPERIMENTAL
Intervention: Live births (9 cases)
Number of subjects: 16
Study 28699212 — intervention group
Group type: COMPARATOR
Intervention: Terminations (5 cases)
Number of subjects: 16
Study 28699212 — intervention group
Group type: COMPARATOR
Intervention: Perinatal deaths (2 cases)
Number of subjects: 16
Study 28699419 — intervention group
Group type: EXPERIMENTAL
Intervention: Five times chair rise test
Number of subjects: 267
Study 28699641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib (300 to 400 mg twice daily)
Number of subjects: 421
Study 28699641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib dose escalation for lack of efficacy
Number of subjects: 421
Study 28699641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib dose reduction due to adverse events
Number of subjects: 421
Study 28699641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib re-escalation after dose reduction
Number of subjects: 421
Study 28699641 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib
Number of subjects: 421
Study 28700265 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza vaccine (IIV4)
Number of subjects: 675
Study 28700265 — intervention group
Group type: COMPARATOR
Intervention: Trivalent influenza vaccine (IIV3) containing B Victoria-lineage strain
Number of subjects: 675
Study 28700265 — intervention group
Group type: COMPARATOR
Intervention: Trivalent influenza vaccine (IIV3) containing B Yamagata-lineage strain
Number of subjects: 675
Study 28700272 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed 640G insulin pump
Number of subjects: 88
Study 28700272 — intervention group
Group type: EXPERIMENTAL
Intervention: Guardian Connect system
Number of subjects: 88
Study 28700272 — intervention group
Group type: EXPERIMENTAL
Intervention: GSR-connected arm sensors
Number of subjects: 88
Study 28701316 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (hs-cTnI)
Number of subjects: 1631
Study 28701316 — intervention group
Group type: COMPARATOR
Intervention: Contemporary cardiac troponin I (cTnI)
Number of subjects: 1631
Study 28701316 — intervention group
Group type: COMPARATOR
Intervention: Contemporary cTnI ≤99th percentile at 0, 3, and 6 h with normal ECG
Number of subjects: 1631
Study 28701316 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnI measurements ≤99th percentile at 0 and 3 h with normal ECG
Number of subjects: 1631
Study 28701316 — intervention group
Group type: COMPARATOR
Intervention: Contemporary cTnI measurements
Number of subjects: 1631
Study 28701316 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary cTnI with serial changes (delta, 0 and 6 h) >150%
Number of subjects: 1631
Study 28701316 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnI with serial testing at 0 and 3 h
Number of subjects: 1631
Study 28701316 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnI with delta hs-cTnI (0 and 3 h) >5 ng/L
Number of subjects: 1631
Study 28701371 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker screening pathway using C-peptide and islet autoantibodies
Number of subjects: 1407
Study 28701371 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker screening pathway
Number of subjects: 1407
Study 28701470 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric Carboxymaltose (FCM) for 24 weeks
Number of subjects: 172
Study 28701470 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 172
Study 28701487 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 5795
Study 28701487 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary-artery bypass grafting (CABG)
Number of subjects: 5795
Study 28701487 — intervention group
Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 5795
Study 28701528 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) 100-129 mm Hg
Number of subjects: 2141
Study 28701528 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) 130-170 mm Hg
Number of subjects: 2141
Study 28701572 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel-based sequencing program
Number of subjects: 418
Study 28701571 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-Paclitaxel (150 mg/m2 weekly for four cycles)
Number of subjects: 81
Study 28702218 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000-calorie deficit feeding and exercise intervention (CR)
Number of subjects: 21
Study 28702218 — intervention group
Group type: COMPARATOR
Intervention: Weight management counseling intervention (WM)
Number of subjects: 21
Study 28702228 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 0
Study 28702228 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study 28702228 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention (DPPOS)
Number of subjects: 0
Study 28702228 — intervention group
Group type: COMPARATOR
Intervention: Metformin (DPPOS)
Number of subjects: 0
Study 28702228 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle and Metformin
Number of subjects: 0
Study 28702291 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal pneumococcal conjugate vaccine
Number of subjects: 88
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 434
Study 28702844 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ASA and LMWH
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated urinary tract infection (UTI)
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: History of cardiovascular disease
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose of LMWH
Number of subjects: 434
Study 28702844 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA medication
Number of subjects: 434
Study 28702877 — intervention group
Group type: EXPERIMENTAL
Intervention: Volixibat
Number of subjects: 8
Study 28704280 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient WRF
Number of subjects: 192
Study 28704280 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent WRF
Number of subjects: 192
Study 28704280 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP decrease less than 30%
Number of subjects: 192
Study 28704412 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic PreImplantation Factor (PIF)
Number of subjects: 0
Study 28704603 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrapatellar fat pad morphology in painful knees of subjects with unilateral knee pain
Number of subjects: 132
Study 28704603 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrapatellar fat pad morphology in chronically painful knees
Number of subjects: 132
Study 28705148 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured peer support (Mentor Mother)
Number of subjects: 497
Study 28705148 — intervention group
Group type: COMPARATOR
Intervention: Unstructured peer support (routine)
Number of subjects: 497
Study 28705182 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and paclitaxel with concurrent radiotherapy (41.4-45 and 50.4 Gy)
Number of subjects: 0
Study 28705184 — intervention group
Group type: EXPERIMENTAL
Intervention: POC IADPSG testing
Number of subjects: 616
Study 28705184 — intervention group
Group type: EXPERIMENTAL
Intervention: POC 1-h 50 g GCT (≥7.2 mmol/L [129.6 mg/dL])
Number of subjects: 616
Study 28705184 — intervention group
Group type: EXPERIMENTAL
Intervention: Other POC tests
Number of subjects: 616
Study 28705184 — intervention group
Group type: COMPARATOR
Intervention: IADPSG testing
Number of subjects: 616
Study 28705187 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation with physiotherapy (mean of ten sessions)
Number of subjects: 473
Study 28705187 — intervention group
Group type: COMPARATOR
Intervention: Initial BI
Number of subjects: 473
Study 28705310 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D vascular ultrasound (3DVUS)
Number of subjects: 3860
Study 28705532 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine-memantine combination
Number of subjects: 0
Study 28705532 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28705547 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 192
Study 28705547 — intervention group
Group type: COMPARATOR
Intervention: Traditional gauze dressing
Number of subjects: 192
Study 28705613 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise rehabilitation (REHAB) following 5-days of bed rest
Number of subjects: 23
Study 28705613 — intervention group
Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 23
Study 28705613 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise rehabilitation (REHAB)
Number of subjects: 23
Study 28705939 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise echocardiography and cardiopulmonary exercise testing at baseline and follow-up
Number of subjects: 0
Study 28705939 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise right heart catheter (RHC) investigations (subgroup)
Number of subjects: 0
Study 28706089 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Fracture Centre (GFC)
Number of subjects: 266
Study 28706089 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Centres (UCC)
Number of subjects: 266
Study 28706090 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised, objective multistep method for site selection
Number of subjects: 266
Study 28706103 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D metabolites and associated hormones measurements in AKI patients
Number of subjects: 230
Study 28706103 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D metabolites and associated hormones measurements in non-AKI patients
Number of subjects: 230
Study 28706500 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity indices
Number of subjects: 1129
Study 28706500 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skills
Number of subjects: 1129
Study 28706563 — intervention group
Group type: EXPERIMENTAL
Intervention: OFC (6/25-12/50 mg/day olanzapine/fluoxetine)
Number of subjects: 255
Study 28706563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 28707175 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndemic score
Number of subjects: 772
Study 28707175 — intervention group
Group type: EXPERIMENTAL
Intervention: Immigrant generation
Number of subjects: 772
Study 28707175 — intervention group
Group type: EXPERIMENTAL
Intervention: Separated orientation
Number of subjects: 772
Study 28707316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 50
Study 28707316 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 50
Study 28707359 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer tracking of daily steps
Number of subjects: 149
Study 28707359 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer wear time
Number of subjects: 149
Study 28707983 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 8034
Study 28707983 — intervention group
Group type: COMPARATOR
Intervention: Normal lung density regions
Number of subjects: 8034
Study 28707983 — intervention group
Group type: EXPERIMENTAL
Intervention: ND-E/I ratio
Number of subjects: 8034
Study 28707987 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine treatment
Number of subjects: 142
Study 28707987 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 142
Study 28708290 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferential adaptive left ventricular-only pacing with the AdaptivCRT
Number of subjects: 0
Study 28708290 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28708962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-EBOV (one shot intramuscular injection)
Number of subjects: 61
Study 28708962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-EBOV (double-shot regimen)
Number of subjects: 61
Study 28708962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-EBOV (both groups)
Number of subjects: 61
Study 28708962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-EBOV (high-dose group)
Number of subjects: 61
Study 28709412 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 0.2% eye micro-drops treatment until retinal vascularization is completed, but for no longer than 90 days.
Number of subjects: 0
Study 28709418 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically active individuals
Number of subjects: 72
Study 28709418 — intervention group
Group type: COMPARATOR
Intervention: Non-physically active individuals
Number of subjects: 72
Study 28709418 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater knee flexion
Number of subjects: 72
Study 28709418 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee flexion
Number of subjects: 72
Study 28709421 — intervention group
Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by St George's Respiratory Questionnaire (SGRQ)
Number of subjects: 623
Study 28709421 — intervention group
Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by UCSD Shortness-of-Breath Questionnaire (SoB)
Number of subjects: 623
Study 28709421 — intervention group
Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by EuroQol visual analogue scale (EQ-5D VAS)
Number of subjects: 623
Study 28709421 — intervention group
Group type: EXPERIMENTAL
Intervention: Health related quality of life measured by Well-being Index (WHO-5)
Number of subjects: 623
Study 28709421 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis of QoL (by SGRQ total)
Number of subjects: 623
Study 28709439 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced antimicrobial de-escalation (EAD)
Number of subjects: 283
Study 28709439 — intervention group
Group type: COMPARATOR
Intervention: Routine antibiotic management (RAM)
Number of subjects: 283
Study 28709774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardio-respiratory fitness (CRF)
Number of subjects: 80
Study 28710110 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-tailored complementary/integrative medicine (CIM) programme, with adherence defined as attending ≥4 CIM treatments, with ≤30 days between each session.
Number of subjects: 388
Study 28710110 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive care (Control group).
Number of subjects: 388
Study 28710215 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG, blood work (biomarkers; gene studies), sleep study (actigraphy), questionnaires, neuropsychological testing at 12 months follow-up
Number of subjects: 0
Study 28710330 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage (ICH) patients
Number of subjects: 2074
Study 28710563 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine administered intravenously
Number of subjects: 33
Study 28710563 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 concentrations measured preoperatively, during surgery, and postoperatively
Number of subjects: 33